Compare CVNA & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVNA | HLN |
|---|---|---|
| Founded | 2012 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.0B | 41.7B |
| IPO Year | 2017 | N/A |
| Metric | CVNA | HLN |
|---|---|---|
| Price | $373.60 | $9.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 1 |
| Target Price | ★ $409.95 | N/A |
| AVG Volume (30 Days) | 3.2M | ★ 9.0M |
| Earning Date | 10-29-2025 | 07-31-2025 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | ★ 4.40 | 0.23 |
| Revenue | ★ $18,266,000,000.00 | $15,096,588,575.00 |
| Revenue This Year | $46.87 | $1.41 |
| Revenue Next Year | $26.36 | $4.52 |
| P/E Ratio | $85.19 | ★ $20.97 |
| Revenue Growth | ★ 45.55 | N/A |
| 52 Week Low | $148.25 | $8.71 |
| 52 Week High | $413.34 | $11.42 |
| Indicator | CVNA | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 62.80 | 57.18 |
| Support Level | $308.50 | $9.65 |
| Resistance Level | $340.79 | $9.84 |
| Average True Range (ATR) | 18.89 | 0.12 |
| MACD | 6.98 | 0.00 |
| Stochastic Oscillator | 95.13 | 62.04 |
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.